NEW YORK (GenomeWeb) – Ag-bio firm DuPont Pioneer announced today that it has acquired an exclusive license to guided Cas9 genome-editing technology from Vilnius University for all commercial uses, including agricultural ones.

Under the deal, DuPont Pioneer and the university will also collaborate on the technology's development. Financial terms of the arrangement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.